Literature DB >> 15184467

Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load.

J Brooks Jackson1, Estelle Piwowar-Manning, LeTanya Johnson-Lewis, Roland Bassett, Lisa M Demeter, Donald Brambilla.   

Abstract

We compared the performance of two UltraSensitive AMPLICOR HIV-1 MONITOR kits (version 1.5 [v1.5] versus v1.0) by retesting 404 plasma samples with low viral loads (<3,000 copies/ml) with both kits. With 292 samples that initially had <50 copies/ml by the v1.0 kit, the v1.5 assay was more sensitive than the v1.0 assay for samples with human immunodeficiency virus type 1 RNA near the 50-copy/ml cutoff (P = 0.0146). Median numbers of copies per milliliter were similar for 112 samples with 50 to 3,000 copies/ml with no difference in sensitivity with a 200-copy/ml cutoff.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15184467      PMCID： PMC427852          DOI： 10.1128/JCM.42.6.2774-2776.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Prevalence and predictive value of intermittent viremia with combination hiv therapy.

Authors:  D V Havlir; R Bassett; D Levitan; P Gilbert; P Tebas; A C Collier; M S Hirsch; C Ignacio; J Condra; H F Günthard; D D Richman; J K Wong
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

2.  Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.

Authors:  B Yen-Lieberman; D Brambilla; B Jackson; J Bremer; R Coombs; M Cronin; S Herman; D Katzenstein; S Leung; H J Lin; P Palumbo; S Rasheed; J Todd; M Vahey; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

3.  Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  R Sun; J Ku; H Jayakar; J C Kuo; D Brambilla; S Herman; M Rosenstraus; J Spadoro
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.

Authors:  D Brambilla; P S Reichelderfer; J W Bremer; D E Shapiro; R C Hershow; D A Katzenstein; S M Hammer; B Jackson; A C Collier; R S Sperling; M G Fowler; R W Coombs
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

5.  Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons.

Authors:  D Brambilla; S Leung; J Lew; J Todd; S Herman; M Cronin; D E Shapiro; J Bremer; C Hanson; G V Hillyer; G D McSherry; R S Sperling; R W Coombs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  A modified ultrasensitive assay to detect quantified HIV-1 RNA of fewer than 50 copies per milliliter.

Authors:  Estelle M Piwowar-Manning; Terry A Henderson; Lorraine Brisbin; J Brooks Jackson
Journal:  Am J Clin Pathol       Date:  2003-08       Impact factor: 2.493

7.  Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.

Authors:  K Triques; J Coste; J L Perret; C Segarra; E Mpoudi; J Reynes; E Delaporte; A Butcher; K Dreyer; S Herman; J Spadoro; M Peeters
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948
  7 in total
  5 in total

1.  Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.

Authors:  Karl Goodkin; Benedetto Vitiello; William D Lyman; Deshratn Asthana; J Hampton Atkinson; Peter N R Heseltine; Rebeca Molina; Wenli Zheng; Imad Khamis; Frances L Wilkie; Paul Shapshak
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

2.  Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubes.

Authors:  Hossein Salimnia; Ellen C Moore; Lawrence R Crane; Rodger D Macarthur; Marilynn R Fairfax
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients.

Authors:  Pedro Castro; Montserrat Plana; Raquel González; Anna López; Anna Vilella; Jose M Nicolas; Teresa Gallart; Tomàs Pumarola; José M Bayas; José M Gatell; Felipe García
Journal:  AIDS Res Hum Retroviruses       Date:  2012-12-16       Impact factor: 2.205

4.  Comparison of the sensitivities of the version 1.5 and version 1.0 ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits at low concentrations of human immunodeficiency virus RNA.

Authors:  Donald J Brambilla; Cheryl Jennings; Ralph Morack; Suzanne Granger; James W Bremer
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

5.  Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study.

Authors:  Jim Young; Martin Rickenbach; Alexandra Calmy; Enos Bernasconi; Cornelia Staehelin; Patrick Schmid; Matthias Cavassini; Manuel Battegay; Huldrych F Günthard; Heiner C Bucher
Journal:  BMC Infect Dis       Date:  2015-09-21       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.